Consensus Report on "Emerging Technology for Pharmaceutical Manufacturing"

Pre-Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
FDA-19-1214278
Agency
Food and Drug Administration Department of Health and Human Services
Responses due
Not on record
Set-aside
No set-aside

Opportunity facts

NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
Not on record
Place of performance
500 5th Street, NW Washington, District of Columbia 20001, United States

Notice details come from SAM.gov. Updated .

Notice text

This synopsis is hereby issued in accordance with FAR Part 5.203 and FAR 6.302 in response to the mandatory requirement for a 15 day notification. The purpose of this synopsis is to announce the Food and Drug Administration's intent to negotiate a Firm Fixed Price sole source award with the National Academies of Science, Engineering, and Medicine (NASEM) located at 500 Fifth Street NW, Washington DC 20001 for a consensus study and report on "Emerging Technology for Pharmaceutical Manufacturing."
Please see attached notice for more details..

Attachments

Files attached to this notice, newest first
File Type Posted
NOI-NASEM.pdf PDF

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Consensus Report on "Emerging Technology for Pharmaceutical Manufacturing" Award Award Notice
Consensus Report on "Emerging Technology for Pharmaceutical Manufacturing" This notice · Latest pre-solicitation Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity